tirzepatide discontinuation weight regain withdrawal - TirzepatideSURMOUNT-3 weight regain following discontinuation of the treatment Understanding Tirzepatide Discontinuation and Weight Regain: What the Science Shows

SURMOUNT-4weight regain The advent of medications like tirzepatide has offered a significant breakthrough for individuals managing obesity and overweight. However, a crucial question arises for many: what happens when tirzepatide treatment is stopped? The data is increasingly clear: tirzepatide discontinuation is strongly linked to weight regain.1757-P: The Rebound Effect—Weight Regain after Tirzepatide ... This article delves into the scientific evidence surrounding this phenomenon, providing an in-depth look at the percentages, timelines, and underlying mechanisms.

The Prevalence and Magnitude of Weight Regain After Tirzepatide Cessation

Multiple studies and analyses highlight a consistent pattern of weight regain following the withdrawal of tirzepatide作者：B Budini·2025·被引用次数：1—The meta-regression shows thatafter 1 year of treatment withdrawal, participants regain 60% of the weightthey lost during treatment.. The SURMOUNT-4 trial, a pivotal study in this area, demonstrated that in participants with obesity or overweight, withdrawing tirzepatide led to substantial regain of lost weightDaily Dose: Tirzepatide Discontinuation Results in Weight .... For most patients, this amounted to over 25% regain within a year of stopping the medication. This significant weight regain signifies a reversal of the cardiometabolic benefits achieved during treatment.作者：DB Horn·被引用次数：3—Afterwithdrawaloftirzepatide, from week 36 to week 88, the mean change in weight increased byweight regaincategory (<25%weight regain, 3.2 ...

Further research quantifies this phenomenon. Some analyses suggest that tirzepatide discontinuation can result in a significant weight regain, with some participants experiencing gains of 11% at three months, 20% at six months, and a substantial 45% at nine months post-cessation.2023年12月11日—Tirzepatideinjection (Zepbound) was associated with a nearly 20 percentage-point difference in meanweightreduction versus placebo from week 36 to week 88. Another study indicated that after stopping tirzepatide, the average weight regained in the first year was 9.9 kg. For comparable medications like semaglutide, some projections show an average regain of 0.2025年12月10日—SURMOUNT-4: Stopping tirzepatide after weight loss led to >25% regain in most patients within a year, reversing cardiometabolic benefits.8 kg (~1Many patients may keep off lost pounds after stopping a ....8 pounds) per month, with a return to baseline weight possible within two years. One meta-regression study even found that after 1 year of treatment withdrawal, participants regain 60% of the weight they lost during treatmentTrajectory of the body weight after drug discontinuation in the ....

It's important to note that the weight regain trajectory can be rapid. Some studies indicate that weight had significantly regained within 8 weeks after treatment discontinuation, showing a continually rising trend. In some instances, complete weight regain has been observed in a notable percentage of users within 24 months of stopping tirzepatide (e.g., 21% in one observed group).

The Underlying Mechanisms of Weight Regain

The rebound effect observed after discontinuing tirzepatide is largely attributed to the drug's mechanism of action.Two Years After Stopping GLP-1s, Most Patients Sustain at ... Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. These hormones play crucial roles in regulating appetite, satiety, and glucose metabolism.Yes, discontinuingtirzepatideleads to significantweight regainin most patients. When tirzepatide treatment stops, the therapeutic effect on appetite and satiety regulation is lost. This leads to an increased hunger and a reduced feeling of fullness, making it more challenging to maintain a calorie deficit.2025年9月9日—Completeweight regainoccurred in 23% of semaglutide, 21% oftirzepatide, and 27% of liraglutide users at 24 months. Weight trajectories ... This loss of the drug's effect on hunger and fullness is a primary driver for weight regain after cessation of therapy.2025年12月31日—“Weight regain after stopping GLP-1 RAs occursdue to loss of the therapeutic effect of appetite and satiety regulation. This is compounded by ...

Cardiometabolic Implications of Weight Regain

The concern regarding weight regain extends beyond aesthetics2023年12月19日—"In participants with obesity or overweight,withdrawing tirzepatide led to substantial regain of lost weight, whereas continued treatment .... The reversal of cardiometabolic benefits is a significant aspect. Studies have shown that individuals experiencing substantial weight regain after tirzepatide withdrawal can see reversals in cardiometabolic parameters back to their baseline levels作者：M Quarenghi·2025·被引用次数：23—The analysis showed thatthere is a rapid regain of weight after cessation of therapy, whether short-term or long-term, with a GLP-1 RA or a GIP/GLP-1 RAs. This .... This underscores the importance of sustained weight management for overall health2025年11月24日—“Overall, at week 88, participants with 75% or moreweight regainaftertirzepatide withdrawalreversed cardiometabolic parameters to baseline ( ....

Sustained Weight Loss and Future Considerations

While weight regain is a considerable risk upon discontinuation of tirzepatide, some research suggests that even after regaining a significant portion of lost weight, participants may still exhibit a net weight loss from their trial baselineTrajectory of the body weight after drug discontinuation in the .... However, the primary message from current research is that tirzepatide is most effective when treatment is continued. The SURMOUNT-4 trial clearly demonstrated that continued treatment with tirzepatide maintained weight loss, whereas withdrawal led to substantial regain.

For individuals considering tirzepatide or other weight-loss medications, understanding the potential for weight regain after discontinuation is paramount. This knowledge, coupled with discussions about long-term management strategies and potential lifestyle interventions, can help patients make informed decisions about their health journey. The research on tirzepatide discontinuation and the subsequent weight regain is an evolving field, and ongoing studies continue to shed light on the long-term effects and management strategies.

Key entities and LSI terms: tirzepatide, weight regain, discontinuation, withdrawal, SURMOUNT-4 trial, obesity, overweight, weight loss, appetite regulation, satiety regulation, cardiometabolic parameters, GLP-1 receptor agonists, GIP/GLP-1 receptor agonists, semaglutide, liraglutide, Mounjaro.作者：M Quarenghi·2025·被引用次数：23—The analysis showed thatthere is a rapid regain of weight after cessation of therapy, whether short-term or long-term, with a GLP-1 RA or a GIP/GLP-1 RAs. This ...